Core Insights - Jinglin Asset has made significant adjustments to its U.S. stock holdings as of the end of Q2 2025, increasing its positions in tech stocks like META, NVIDIA, and Google while liquidating positions in Apple, Pfizer, Legend Biotech, and ZTO Express [1][2] Group 1: Portfolio Adjustments - The top ten holdings of Jinglin Asset now include META, NetEase, Manbang, Pinduoduo, Futu Holdings, Qifu Technology, NVIDIA, Beike, New Oriental, and Nebius, indicating a strong focus on Chinese stocks alongside tech investments [2] - As of the end of Q2, Jinglin Asset's holdings in META accounted for 25.46% of its portfolio, valued at over $730 million [2] - The firm strategically sold approximately 38,000 shares of NVIDIA in Q1 but repurchased 630,000 shares in Q2, reflecting a bullish outlook on the company's valuation and fundamentals [2] Group 2: Market Outlook - Jinglin Asset has also initiated positions in Atour and Huazhu, purchasing 210,000 and 177,000 shares respectively, signaling confidence in the recovery of the Chinese market [3] - The company expressed optimism about China's development prospects over the next few years, highlighting a shift in global perceptions of Chinese companies from being undervalued to attracting renewed investment [3]
千亿巨头，精准抄底！重仓中国资产
Zhong Guo Zheng Quan Bao·2025-08-10 04:43